Weekly Recap: HA1406 Phase III success and CSPC Innovation H1 profitTradingView·2 hours ago01093-0.58%300765+0.42%
CSPC Pharma says China clears clinical trial for RSV vaccine candidate SYS 6057PUBT·2 days ago, 04:56 AM01093-0.58%
CSPC says FDA clears CRB-701 pivotal trial in second-line oropharyngeal cancerPUBT·Jul 29 at 07:34 AMCRBP-0.88%01093-0.58%
CSPC PHARMA Marketing Application for Sirolimus for Injection AcceptedAASTOCKS News·Jul 27 at 09:07 PM01093-0.58%
CSPC PHARMA HA1406 Enteric-coated Tablets for Depression Treatment Meet Primary Endpoint in Phase III Clinical TrialAASTOCKS News·Jul 27 at 09:07 PM01093-0.58%
Morgan Stanley Remains a Buy on CSPC Pharmaceutical Group (CHJTF)Tip Ranks·Jul 28 at 07:36 PM01093-0.58%
CSPC says China NMPA accepts sirolimus albumin-bound injection filing, grants priority reviewPUBT·Jul 27 at 07:58 AM01093-0.58%300765+0.42%
CSPC PHARMA Expects Interim Consolidated Profit of Approximately RMB5.9B-6.2BAASTOCKS News·Jul 27 at 04:44 AM01093-0.58%300765+0.42%
CSPC Innovation Pharma, CSPC Pharmaceutical Group unit, forecasts H1 net profit at 1.18 billion-1.36 billion yuanPUBT·Jul 27 at 04:34 AM01093-0.58%300765+0.42%
CSPC Pharma expects H1 profit attributable to owners at RMB 5.9 billion-RMB 6.2 billionPUBT·Jul 27 at 04:32 AM01093-0.58%AZN-0.99%
CSPC Sees Profit Surge on AstraZeneca Deal and Solid Drug SalesTip Ranks·Jul 27 at 04:37 AM01093-0.58%AZN-0.99%
Nomura Cuts CSPC PHARMA TP to HKD10.31, Expects Mild Growth in 2Q Drug SalesAASTOCKS News·Jul 26 at 10:47 PM01093-0.58%
Sino Biopharmaceutical Forms Indonesia Joint Venture With Tempo ScanTip Ranks·Jul 27 at 04:11 AM01177+0.20%
Nomura Expects AKESO to Swing to Interim Profit of RMB46M, Maintains Buy RatingAASTOCKS News·Jul 26 at 11:59 PM09926-0.64%
